Interference of Endurance Training on Strength Development and Neuromuscular Adaptations

November 27, 2024 updated by: Miguel Gomes, University of Lisbon

This study aims to find out if performing combined strength and endurance exercise in the same program (called concurrent training-CT) leads to similar long-term improvements in neuromuscular function as doing each type of exercise separately. The main questions it seeks to answer are:

Does performing CT result in similar improvements in strength and power as doing just strength training? Does performing CT result in similar improvements in cardiorespiratory fitness as doing just endurance training? Are neuromuscular adaptations similar between CT and just strength training? Researchers will compare the results between three groups: the CT group, the endurance training group (E), and the strength training group (S) to answer these questions.

Study Overview

Detailed Description

This study looks at how different types of exercise affect neuromuscular and cardiorespiratory improvements over time. It aims to see how combining strength and endurance training (concurrent training - CT) affects neuromuscular and cardiorespiratory adaptations compared to doing just strength or endurance training. Participants who regularly do both types of exercise will be split into three groups: Concurrent training (CT), endurance training (E), or strength training (S) and will be involved in 11 weeks of supervised training, three days a week:

Endurance training involves 30 minutes of continuous running, three days a week, at an intensity corresponding to the heavy domain (between the first and second ventilatory threshold) Strength training includes weightlifting three days a week, focusing on building both strength and power.

Concurrent training incorporates both strength and endurance exercises in the same session, three days a week, with strength training being executed prior to endurance training.

Researchers will collect data at three time-points during the 11 weeks: before starting the program (Baseline), at the end of week 5 (Week 5), and at the end of the program (Week 11). Measurements include lower-body strength and power, aerobic capacity, nerve evoked responses, and muscle structure if the quadriceps femoris.

Researchers will then compare the CT, E, and S groups at each measurement point to see which type of training elicited the best adaptations for the different neuromuscular and cardiorespiratory outcomes.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cruz Quebrada - Dafundo
      • Lisboa, Cruz Quebrada - Dafundo, Portugal, 1499-002
        • Faculdade de Motricidade Humana - Universidade de Lisboa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Active training status (strength and endurance (running) exercise at least 2 times per week over the last three months prior to inclusion in the study)

Exclusion Criteria:

  • Active smoking status
  • Orthopedic injuries
  • On medication
  • Known cardiovascular or respiratory disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Endurance
30 minutes of running at an intensity corresponding to the heavy-domain (between the first and second ventilatory thresholds)
Experimental: Strength
Combination of strength and power exercises Weeks 1-5 focus on building maximal strength Weeks 6-11 focus on maintaining maximal strength and improve muscle power
Experimental: Concurrent
Combining both strength and endurance training programs, with strength preceding endurance, incorporating a 20-min rest period between each modality

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surface EMG
Time Frame: Baseline, Week 5, Week 11
Using surface electromyography (EMG), the muscle activation of the plantarflexors muscles will me assessed, as well as the quadriceps femoris during the leg press and back squat exercise
Baseline, Week 5, Week 11
H-reflex excitability
Time Frame: Baseline, Week 5, Week 11
Using percutaneous electrostimulation of the tibial nerve, spinal reflex excitability will be explored by assessing H-reflex evoked responses
Baseline, Week 5, Week 11
V-wave
Time Frame: Baseline, Week 5, Week 11
Using percutaneous electrostimulation of the tibial nerve, neural drive to the active muscle will be assessed by measuring V-wave amplitudes
Baseline, Week 5, Week 11
Maximal Isometric Strength
Time Frame: Baseline, Week 5, Week 11
Maximal voluntary isometric strength of the plantarflexors and leg press exercise in Newtons
Baseline, Week 5, Week 11
Maximal Dynamic Strength
Time Frame: Baseline, Week 5, Week 11
Maximal dynamic strength on the back squat exercise in kilograms lifted
Baseline, Week 5, Week 11
Lower Body Muscle Power
Time Frame: Baseline, Week 5, Week 11
Lower body muscle power in watts will be assessed during countermovement jumps
Baseline, Week 5, Week 11
Muscle fascicle length
Time Frame: Baseline, Week 5, Week 11
Fascicle length of the vastus lateralis muscles in centimeters
Baseline, Week 5, Week 11
Muscle fascicle pennation angle
Time Frame: Baseline, Week 5, Week 11
Pennation angle of the vastus laterais fascicles, in degrees
Baseline, Week 5, Week 11
Muscle thickenss
Time Frame: Baseline, Week 5, Week 11
Muscle thickenss of the vastus lateralis, in centimeters
Baseline, Week 5, Week 11

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2022

Primary Completion (Actual)

July 30, 2024

Study Completion (Estimated)

July 30, 2025

Study Registration Dates

First Submitted

April 8, 2024

First Submitted That Met QC Criteria

April 19, 2024

First Posted (Actual)

April 22, 2024

Study Record Updates

Last Update Posted (Actual)

December 3, 2024

Last Update Submitted That Met QC Criteria

November 27, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on Endurance Exercise

Subscribe